CTIB Fundamental Analysis - YUNHONG CTI LTD

Name: YUNHONG CTI LTD (CTIB) Stock
Brand: YUNHONG CTI LTD
Rating: 3.5 (3 reviews)

Fundamental Rating

CTIB gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 61 industry peers in the Household Durables industry. CTIB has a bad profitability rating. Also its financial health evaluation is rather negative. CTIB is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

CTIB had negative earnings in the past year.

CTIB had a positive operating cash flow in the past year.

In the past 5 years CTIB always reported negative net income.

The reported operating cash flow has been mixed in the past 5 years: CTIB reported negative operating cash flow in multiple years.

1.2 Ratios

The profitability ratios for CTIB are negative, so there is not much use analyzing them.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 17.33%, CTIB is not doing good in the industry: 92.54% of the companies in the same industry are doing better.

CTIB's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for CTIB so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	17.33%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y8.6%

GM growth 5Y-6.59%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CTIB does not have a ROIC to compare to the WACC, probably because it is not profitable.

CTIB has more shares outstanding than it did 1 year ago.

Compared to 1 year ago, CTIB has an improved debt to assets ratio.

2.2 Solvency

CTIB has an Altman-Z score of 1.38. This is a bad value and indicates that CTIB is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of CTIB (1.38) is worse than 79.10% of its industry peers.

CTIB has a debt to FCF ratio of 11.30. This is a negative value and a sign of low solvency as CTIB would need 11.30 years to pay back of all of its debts.

CTIB has a Debt to FCF ratio of 11.30. This is in the lower half of the industry: CTIB underperforms 67.16% of its industry peers.

A Debt/Equity ratio of 1.10 is on the high side and indicates that CTIB has dependencies on debt financing.

CTIB's Debt to Equity ratio of 1.10 is on the low side compared to the rest of the industry. CTIB is outperformed by 77.61% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.1
Debt/FCF	11.3
Altman-Z	1.38

ROIC/WACCN/A

WACC9.25%

2.3 Liquidity

CTIB has a Current Ratio of 1.29. This is a normal value and indicates that CTIB is financially healthy and should not expect problems in meeting its short term obligations.

CTIB has a worse Current ratio (1.29) than 88.06% of its industry peers.

CTIB has a Quick Ratio of 1.29. This is a bad value and indicates that CTIB is not financially healthy enough and could expect problems in meeting its short term obligations.

CTIB has a worse Quick ratio (0.41) than 94.03% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.29
Quick Ratio	0.41

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 94.62% over the past year.

Looking at the last year, CTIB shows a very negative growth in Revenue. The Revenue has decreased by -17.59% in the last year.

CTIB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.33% yearly.

EPS 1Y (TTM)94.62%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%90%

Revenue 1Y (TTM)-17.59%

Revenue growth 3Y-17.61%

Revenue growth 5Y-20.33%

Sales Q2Q%-8.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CTIB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CTIB indicates a slightly more expensive valuation: CTIB is more expensive than 68.66% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	89.15
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CTIB!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

YUNHONG CTI LTD

NASDAQ:CTIB (9/22/2023, 8:00:01 PM)

After market: 2.36 -0.04 (-1.67%)

2.4

+0.43 (+21.83%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Durables & Apparel

GICS IndustryHousehold Durables

Earnings (Last)08-03 2023-08-03/bmo

Earnings (Next)N/A N/A

Inst Owners2.18%

Inst Owner Change-0.07%

Ins Owners8.57%

Ins Owner Change0%

Market Cap48.23M

Revenue(TTM)16.94M

Net Income(TTM)-991.00K

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.85
P/FCF	89.15
P/OCF	68.51
P/B	12.4
P/tB	12.4
EV/EBITDA	N/A

EPS(TTM)-0.11

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.03

FCFY1.12%

OCF(TTM)0.04

OCFY1.46%

SpS0.84

BVpS0.19

TBVpS0.19

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	17.33%
FCFM	3.19%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y8.6%

GM growth 5Y-6.59%

F-Score3

Asset Turnover1.08

Health

		Industry Rank	Sector Rank
Debt/Equity	1.1
Debt/FCF	11.3
Debt/EBITDA	N/A
Cap/Depr	48.08%
Cap/Sales	0.96%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.29
Quick Ratio	0.41
Altman-Z	1.38

F-Score3

WACC9.25%

ROIC/WACCN/A

Cap/Depr(3y)37.17%

Cap/Depr(5y)31%

Cap/Sales(3y)0.72%

Cap/Sales(5y)0.67%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)94.62%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%90%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-17.59%

Revenue growth 3Y-17.61%

Revenue growth 5Y-20.33%

Sales Q2Q%-8.13%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-547.32%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-72.59%

FCF growth 3Y-15%

FCF growth 5Y34.02%

OCF growth 1Y-67.25%

OCF growth 3Y-13.59%

OCF growth 5Y13.45%

YUNHONG CTI LTD / CTIB FAQ

Can you provide the ChartMill fundamental rating for YUNHONG CTI LTD?

ChartMill assigns a fundamental rating of 1 / 10 to CTIB.

Can you provide the valuation status for YUNHONG CTI LTD?

ChartMill assigns a valuation rating of 0 / 10 to YUNHONG CTI LTD (CTIB). This can be considered as Overvalued.

Can you provide the profitability details for YUNHONG CTI LTD?

YUNHONG CTI LTD (CTIB) has a profitability rating of 1 / 10.

What is the financial health of YUNHONG CTI LTD (CTIB) stock?

The financial health rating of YUNHONG CTI LTD (CTIB) is 1 / 10.

YUNHONG CTI LTD (CTIB) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

YUNHONG CTI LTD / CTIB FAQ

Can you provide the ChartMill fundamental rating for YUNHONG CTI LTD?

Can you provide the valuation status for YUNHONG CTI LTD?

Can you provide the profitability details for YUNHONG CTI LTD?

What is the financial health of YUNHONG CTI LTD (CTIB) stock?